Cargando…
Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis
Cervical cancer is one of the most diagnosed malignancies among females. The 5-fluorouracil (5-Fu) is a widely used chemotherapeutic agent against diverse cancers. Despite the initially encouraging progresses, a fraction of cervical cancer patients developed 5-Fu resistance. We detected that nuclear...
Autores principales: | Shao, Xuecheng, Zheng, Xuehui, Ma, Dan, Liu, Yang, Liu, Guoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298262/ https://www.ncbi.nlm.nih.gov/pubmed/33645623 http://dx.doi.org/10.1042/BSR20200533 |
Ejemplares similares
-
LncRNA NEAT1 knockdown attenuates autophagy to elevate 5‐FU sensitivity in colorectal cancer via targeting miR‐34a
por: Liu, Fen, et al.
Publicado: (2019) -
HuR‐regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer
por: Chai, Yiqing, et al.
Publicado: (2016) -
LncRNA NEAT1 remodels chromatin to promote the 5-Fu resistance by maintaining colorectal cancer stemness
por: Zhu, Yihao, et al.
Publicado: (2020) -
LncRNA NEAT1 promotes glioma cancer progression via regulation of miR-98-5p/BZW1
por: Li, Yabin, et al.
Publicado: (2021) -
Inhibition of LncRNA-NEAT1 alleviates intestinal epithelial cells (IECs) dysfunction in ulcerative colitis by maintaining the homeostasis of the glucose metabolism through the miR-410-3p-LDHA axis
por: Ni, Siyi, et al.
Publicado: (2022)